Sunrise Healthcare

Jardiance (empagliflozin) is a prescription medication used to lower blood sugar in adults and children aged 10 and older with type 2 diabetes. It also reduces the risk of cardiovascular death, heart failure hospitalization, and the progression of chronic kidney disease in adults. It works by helping kidneys remove sugar.

Glycoheal 500 MG Tablet is primarily used to manage type 2 diabetes mellitus by controlling blood sugar levels and preventing complications like kidney damage. It is also prescribed for polycystic ovary syndrome (PCOS) to regulate menstrual cycles and improve insulin sensitivity. Additionally, it may support modest weight loss in patients.

Glycoheal 850 mg is an oral medication primarily used to manage type 2 diabetes mellitus. It contains Metformin Hydrochloride, which helps control blood sugar levels by reducing glucose production in the liver, decreasing intestinal absorption, and improving insulin sensitivity. It is also prescribed off-label for polycystic ovary syndrome (PCOS).

Mounjaro is an injectable prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes

Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes.You'll inject Mounjaro once per week, and you can take your dose at the time of day that works best for you. But you should use Mounjaro on the same day each week.Tirzepatide (Mounjaro) is a medication approved for the treatment of type 2 diabetes, but it has shown incredible results for weight loss, even for people who do not have diabetes

Mounjaro 12.5 mg is a once-weekly Tirzepatide injection, delivered via a pre-filled, single-use subcutaneous pen. Tirzepatide is a cutting-edge dual GIP and GLP-1 receptor agonist designed for adults with type 2 diabetes mellitus to improve blood sugar control, alongside diet and exercise. It is also being researched and prescribed off-label for weight management in obesity, under medical supervision.

Glyciphage 500 MG is an anti-diabetic medication used to treat type 2 diabetes mellitus by regulating blood sugar levels and increasing insulin sensitivity. It also manages Polycystic Ovary Syndrome (PCOS) in women, helping to balance hormones and regulate menstrual cycles. Additionally, it aids in weight management and prevents diabetes-related complications.

Mounjaro 15mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Mounjaro 5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Mounjaro 2.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 2.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Mounjaro 2.5mg kwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 2.5mg kwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Mounjaro 15mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.